{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:37:48Z","timestamp":1785235068751,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.antiviral.2008.09.002","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T16:42:24Z","timestamp":1223484144000},"page":"56-63","source":"Crossref","is-referenced-by-count":50,"title":["New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3"],"prefix":"10.1016","volume":"81","author":[{"given":"Michaela","family":"Schmidtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"Zieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga B.","family":"Riabova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim A.","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2008.09.002_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0166-3542(91)90001-8","article-title":"A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program","volume":"16","author":"Andries","year":"1991","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.09.002_bib2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.36.1.100","article-title":"In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity","volume":"36","author":"Andries","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.09.002_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JVI.64.3.1117-1123.1990","article-title":"Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity","volume":"64","author":"Andries","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2174\/138161206776361129","article-title":"Current status of anti-picornavirus therapies","volume":"12","author":"Barnard","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.antiviral.2008.09.002_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.antiviral.2006.12.001","article-title":"Antiviral treatment of Coxsackie B virus infection in human pancreatic islets","volume":"74","author":"Berg","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.09.002_bib6","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1055\/s-2001-18070","article-title":"Mild regioselective halogenation of activated pyridines with N-bromosuccinimide","volume":"14","author":"Canibano","year":"2001","journal-title":"Synthesis"},{"issue":"6","key":"10.1016\/j.antiviral.2008.09.002_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"De Palma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2008.09.002_bib8","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1021\/jm00074a004","article-title":"Antipicornavirus activity of tetrazole analogues related to disoxaril","volume":"36","author":"Diana","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.09.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632029300400101","article-title":"Antipicornavirus compounds: use of rational drug design and molecular modelling","volume":"4","author":"Diana","year":"1993","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2008.09.002_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/jm00008a014","article-title":"Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism","volume":"38","author":"Diana","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.09.002_bib11","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jo01351a092","article-title":"Dimethylformamide as a useful solvent in preparing nitriles from aryl halides as cuprous cyanide; improved isolation techniques","volume":"26","author":"Friedman","year":"1961","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.antiviral.2008.09.002_bib12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/314758","article-title":"Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants","volume":"179","author":"Groarke","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.09.002_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/jmbi.1995.0536","article-title":"Structural studies on human rhinovirus 14 drug-resistant compensation mutants","volume":"253","author":"Hadfield","year":"1995","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/135965350200700107","article-title":"Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials","volume":"7","author":"Hayden","year":"2002","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2008.09.002_bib15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2008.09.002_bib16","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1128\/JVI.63.6.2476-2485.1989","article-title":"Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound","volume":"63","author":"Heinz","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-3542(00)00106-6","article-title":"In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses","volume":"47","author":"Kaiser","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.09.002_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/jmbi.1993.1137","article-title":"A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A","volume":"230","author":"Kim","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib19","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1128\/JVI.70.11.7811-7818.1996","article-title":"A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3","volume":"70","author":"Knowlton","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib20","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1021\/jm0704806","article-title":"Quantitative structure\u2013activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication","volume":"50","author":"Kuz\u2019min","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2008.09.002_bib21","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1128\/JVI.78.7.3663-3674.2004","article-title":"VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds","volume":"78","author":"Ledford","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2005.08.003","article-title":"Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril","volume":"68","author":"Ledford","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.09.002_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/0091270005283286","article-title":"The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe","volume":"46","author":"Ma","year":"2006","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/dki055","article-title":"Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication","volume":"55","author":"Makarov","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2008.09.002_bib25","first-page":"655","article-title":"Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses","volume":"vol. 1","author":"Melnick","year":"1996"},{"key":"10.1016\/j.antiviral.2008.09.002_bib26","first-page":"369","article-title":"Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice","volume":"2","author":"Merkle","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0969-2126(01)00201-5","article-title":"The structure of coxsackievirus B3 at 3 5 A resolution","volume":"3","author":"Muckelbauer","year":"1995","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2008.09.002_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0969-2126(93)90008-5","article-title":"The structure of human rhinovirus 16","volume":"1","author":"Oliveira","year":"1993","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2008.09.002_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2006.03.011","article-title":"Rhinovirus chemotherapy","volume":"71","author":"Patick","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2008.09.002_bib30","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of pleconaril against enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2008.09.002_bib31","first-page":"795","article-title":"Picornaviridae: the viruses and their replication","volume":"vol. 1","author":"Racaniello","year":"2007"},{"key":"10.1016\/j.antiviral.2008.09.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/viro.2000.0485","article-title":"Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1","volume":"275","author":"Schmidtke","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2008.09.002_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00305-6","article-title":"A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1","volume":"95","author":"Schmidtke","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2008.09.002_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dki263","article-title":"Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment","volume":"56","author":"Schmidtke","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2008.09.002_bib35","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/jmv.20933","article-title":"The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice","volume":"79","author":"Schmidtke","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2008.09.002_bib36","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1128\/JVI.78.20.11061-11069.2004","article-title":"Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208003926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354208003926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T09:56:21Z","timestamp":1684576581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354208003926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0166354208003926"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2008.09.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}